IQVIA Partners with AWS to Transform Healthcare with AI

The collaboration aims to revolutionize clinical trial automation, medical affairs, and analytics through IQVIA's innovative agentic AI platform. By deploying its AI capabilities on AWS, IQVIA seeks to enhance scalable, secure, and intelligent automation across various healthcare processes. This strategic initiative is expected to not only improve the efficiency of clinical trial execution but also accelerate the overall trial processes, thereby fostering rapid drug development and delivery.

Lucas Glass, Senior Vice President of Architecture and Standards at IQVIA, expressed enthusiasm about the partnership, stating, "We are excited to move forward with AWS as IQVIA’s Preferred Agentic Cloud Provider. Our AI platform aims to empower life sciences organizations to innovate faster and deliver treatments to patients more efficiently."

In addition to deploying its AI platform, IQVIA and AWS have committed to exploring new opportunities within life science analytics. The goal is to drive the next generation of data-driven insights and solutions that can significantly impact the industry. As Glass noted, the integration of agentic AI will unlock new possibilities for clients and the broader life sciences landscape.

The partnership is particularly significant given that 90% of the world’s largest pharmaceutical companies currently rely on both IQVIA and AWS to facilitate their digital transformation and analytics efforts. This collaboration reinforces the companies' commitment to democratizing AI in life sciences, ultimately accelerating drug innovation and improving patient outcomes globally.

Allyson Fryhoff, Director of Global Healthcare and Life Sciences at AWS, expressed her excitement about this collaboration, stating, "We are thrilled to support IQVIA’s Agentic AI platform with the full breadth of AWS’s cloud capabilities. Together, we aim to help the life sciences industry leverage the power of AI to support ongoing innovation in healthcare and achieve outcomes once thought impossible."

This partnership signals a new era of agentic AI in life sciences, where intelligent, cloud-powered solutions are poised to drive greater efficiency, foster innovation, and significantly enhance patient outcomes.

IQVIA is a recognized global leader in providing clinical research services, commercial insights, and healthcare intelligence. With its innovative portfolio powered by IQVIA Connected Intelligence™, the company delivers actionable insights and services built on high-quality health data, advanced analytics, and extensive domain expertise. With a workforce of approximately 91,000 employees in over 100 countries, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments, thereby improving patient outcomes and population health worldwide.

AWS, the most comprehensive and broadly adopted cloud platform since its inception in 2006, continues to expand its services to meet virtually any workload. With over 240 fully featured services ranging from computing and storage to machine learning and artificial intelligence, AWS supports millions of customers, including startups, enterprises, and government agencies, in their quest to become more agile and cost-effective.

This strategic collaboration between IQVIA and AWS positions both companies at the forefront of innovation in healthcare, paving the way for advancements that could redefine patient care and clinical research in the years to come.